Indonesia · Delayed Price · Currency is IDR PT Suparma Tbk Statistics
Total Valuation
PT Suparma Tbk has a market cap or net worth of IDR 852.87 billion. The enterprise value is 1.53 trillion.
| Market Cap | 852.87B |
| Enterprise Value | 1.53T |
Important Dates
The next estimated earnings date is Tuesday, May 5, 2026.
| Earnings Date | May 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PT Suparma Tbk has 4.10 billion shares outstanding. The number of shares has decreased by -0.09% in one year.
| Current Share Class | 4.10B |
| Shares Outstanding | 4.10B |
| Shares Change (YoY) | -0.09% |
| Shares Change (QoQ) | -0.16% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 0.02% |
| Float | 313.67M |
Valuation Ratios
The trailing PE ratio is 8.25.
| PE Ratio | 8.25 |
| Forward PE | n/a |
| PS Ratio | 0.31 |
| PB Ratio | 0.34 |
| P/TBV Ratio | 0.34 |
| P/FCF Ratio | 1.69 |
| P/OCF Ratio | 1.40 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.93, with an EV/FCF ratio of 3.04.
| EV / Earnings | 14.85 |
| EV / Sales | 0.56 |
| EV / EBITDA | 4.93 |
| EV / EBIT | 8.33 |
| EV / FCF | 3.04 |
Financial Position
The company has a current ratio of 1.90, with a Debt / Equity ratio of 0.31.
| Current Ratio | 1.90 |
| Quick Ratio | 0.34 |
| Debt / Equity | 0.31 |
| Debt / EBITDA | 2.45 |
| Debt / FCF | 1.51 |
| Interest Coverage | 5.45 |
Financial Efficiency
Return on equity (ROE) is 4.22% and return on invested capital (ROIC) is 4.66%.
| Return on Equity (ROE) | 4.22% |
| Return on Assets (ROA) | 3.21% |
| Return on Invested Capital (ROIC) | 4.66% |
| Return on Capital Employed (ROCE) | 6.30% |
| Weighted Average Cost of Capital (WACC) | 5.55% |
| Revenue Per Employee | 3.35B |
| Profits Per Employee | 125.35M |
| Employee Count | 824 |
| Asset Turnover | 0.77 |
| Inventory Turnover | 2.13 |
Taxes
In the past 12 months, PT Suparma Tbk has paid 28.61 billion in taxes.
| Income Tax | 28.61B |
| Effective Tax Rate | 21.69% |
Stock Price Statistics
The stock price has increased by +4.00% in the last 52 weeks. The beta is 0.57, so PT Suparma Tbk's price volatility has been lower than the market average.
| Beta (5Y) | 0.57 |
| 52-Week Price Change | +4.00% |
| 50-Day Moving Average | 218.12 |
| 200-Day Moving Average | 235.15 |
| Relative Strength Index (RSI) | 39.50 |
| Average Volume (20 Days) | 435,995 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, PT Suparma Tbk had revenue of IDR 2.76 trillion and earned 103.29 billion in profits. Earnings per share was 25.21.
| Revenue | 2.76T |
| Gross Profit | 415.92B |
| Operating Income | 184.05B |
| Pretax Income | 131.90B |
| Net Income | 103.29B |
| EBITDA | 305.68B |
| EBIT | 184.05B |
| Earnings Per Share (EPS) | 25.21 |
Balance Sheet
The company has 81.86 billion in cash and 762.55 billion in debt, with a net cash position of -680.69 billion or -166.01 per share.
| Cash & Cash Equivalents | 81.86B |
| Total Debt | 762.55B |
| Net Cash | -680.69B |
| Net Cash Per Share | -166.01 |
| Equity (Book Value) | 2.50T |
| Book Value Per Share | 610.64 |
| Working Capital | 746.19B |
Cash Flow
In the last 12 months, operating cash flow was 608.49 billion and capital expenditures -104.19 billion, giving a free cash flow of 504.29 billion.
| Operating Cash Flow | 608.49B |
| Capital Expenditures | -104.19B |
| Depreciation & Amortization | 121.63B |
| Net Borrowing | -553.58B |
| Free Cash Flow | 504.29B |
| FCF Per Share | 122.99 |
Margins
Gross margin is 15.09%, with operating and profit margins of 6.68% and 3.75%.
| Gross Margin | 15.09% |
| Operating Margin | 6.68% |
| Pretax Margin | 4.78% |
| Profit Margin | 3.75% |
| EBITDA Margin | 11.09% |
| EBIT Margin | 6.68% |
| FCF Margin | 18.29% |
Dividends & Yields
PT Suparma Tbk does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.09% |
| Shareholder Yield | 0.09% |
| Earnings Yield | 12.11% |
| FCF Yield | 59.13% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on November 10, 2025. It was a forward split with a ratio of 1.3.
| Last Split Date | Nov 10, 2025 |
| Split Type | Forward |
| Split Ratio | 1.3 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |